May 1, 2017
Latest niche market "Global Cancer Supportive Care Therapeutics Market to 2022-Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets" by Orbis Research
Dallas, United States - May 1, 2017 /MarketersMedia/ —
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in this report are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise.
Buy a report @ http://www.orbisresearch.com/contact/purchase/275013.
Reasons to buy
This report will allow you to -
- Understand the current clinical and commercial landscape through a comprehensive study of disease pathogenesis, symptoms, diagnosis and prognosis for the key indications covered in the report
- Understand the current treatment landscape, with profiles of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Identify the key pipeline products, with a particular focus on those due to be brought to market in the near future, as well as sales forecasts for these products.
- Predict growth in market size, with in-depth market forecasting from 2015 to 2022. The forecast will provide an understanding of how epidemiology trends, new drug entries and new drug patents expirations will influence market value.
- Identify the leading companies in the market, in terms of market share and growth. Company analysis illustrates how dependent the key companies in the market are on revenue derived from cancer supportive care products. In addition, analysis determines the primary factors that will drive market growth for the key companies in the market.
- Identify commercial opportunities in the cancer supportive care deals landscape by analyzing trends in licensing and co-development deals.
Check the DISCOUNT @ http://www.orbisresearch.com/contacts/discount/275013.
Scope
The cancer supportive care market already contains some commercially successful products.
- Which classes of drug dominate the market?
- Which indication is the most commercially successful?
- How will commercially successful drugs perform over the forecast period?
The cancer supportive care pipeline is relatively small, but there is significant diversity in terms of molecule types and targets.
- Which molecular targets appear most frequently in the pipeline?
- What are the commercial prospects for the most promising late-stage pipeline products?
The cancer supportive care market is forecast to grow from $11.7 billion in 2015 to $12.4 billion in 2022, at a compound annual growth rate of 0.9%.
- Which products are forecast to drive growth?
- Will generic and biosimilar competition have a significant impact on the market over the forecast period?
The company landscape is becoming increasingly competitive.
- What are the leading companies in terms of market share?
- Which companies are forecast to experience the greatest growth in market share?
- What are the drivers of growth for key companies in the market?
- How dependent are the key companies on this disease cluster for revenue?
The level of unmet need within the cancer supportive care therapy area varies between indications. CIN and CINV both already have treatment regimens that can significantly decrease the incidence rate. However, the level of unmet need for CIA, cancer pain, oral mucositis and bone metastasis is high, with treatment focusing heavily on alleviating the symptoms instead of treating the underlying cause.
There are 245 products in active development in the cancer supportive care pipeline, but this includes products in development for smaller and less commercially significant indications. There are 169 products in active development for the key indication examined in this report, giving an average of 28 products per indication, the majority of which are at an early stage of development.
Read the more detail of this report @ http://www.orbisresearch.com/reports/index/global-cancer-supportive-care-therapeutics-market-to-2022-patent-expirations-create-opportunities-for-biosimilars-in-the-chemotherapy-induced-anemia-and-neutropenia-markets.
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: [email protected]
Organization: Orbis Research
Address: 144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A.
Phone: +912064101019
For more information, please visit http://www.orbisresearch.com/reports/index/global-cancer-supportive-care-therapeutics-market-to-2022-patent-expirations-create-opportunities-for-biosimilars-in-the-chemotherapy-induced-anemia-and-neutropenia-markets
Source: MarketersMedia
Release ID: 192383
An airstrike on a bustling market in rebel territory left at least 50 people dead, in one of the deadliest attacks on civilians in months.
Nvidia founder and CEO Jensen Huang and AMD chief Lisa Su have joined an influential advisory board at a prestigious Chinese university, placing the two key American AI tech leaders in a high-level forum known for connecting global executives with senior Chinese officials. Huang and Su were among three new members appointed to the advisory board of Tsinghua University’s School of Economics and Management (SEM), alongside Marc Pictet, senior managing partner of Swiss wealth and assets manager...
China’s generative artificial intelligence user base surpassed 700 million at the end of June, accounting for more than half of the population as wide AI adoption pushes the technology’s penetration rate to a record high in the country. The user base data, released Tuesday by the China Internet Network Information Centre, represents an increase of 16 per cent from the end of 2025, when China had 602 million generative AI users with a penetration rate of 42.8 per cent. Question-and-answer...
Tens of thousands of people thronged Apple stores in India this month to snap up the newest iPhone models – the 18 Pro and Pro Max – but the frenzy has kicked off public debate in the country about affordability and consumer debt. The iPhone 18 Pro starts at 164,900 rupees (US$1,700) and goes up to 179,000 rupees, while the iPhone 18 Pro Max starts at 179,900 rupees and maxes out at 329,900 rupees. Apple also unveiled the iPhone Duo, its first-ever folding smartphone, essentially setting a new...
A Vietnamese pro-democracy organisation has alleged that two of its members, who hold Norwegian and Australian citizenship, were abducted in Cambodia and taken to the border with Vietnam, where Hanoi authorities later accused them of illegally entering the country. Vietnam has charged the two men, along with a third alleged member of the organisation, with terrorism and document forgery, saying they were caught crossing the border from Cambodia with forged identity documents. The organisation,...
Malaysia says it is repatriating undocumented migrants from Myanmar who want to return. Critics say it is putting their lives at risk.
The Victorian heroine has long been celebrated in China for her independence and insistence on equality.
Hong Kong businesses are lagging behind their mainland Chinese peers in adopting artificial intelligence, as entrenched legacy systems and a risk-averse corporate mindset slow the city’s digital transition, according to a senior executive at consultancy Accenture. Only 10 per cent of Hong Kong firms surveyed by Accenture had integrated generative AI across multiple business functions, compared with about 21 per cent of mainland enterprises, said Robert Hah, Hong Kong office lead at Accenture...
US President Donald Trump’s recent endorsement of a trade corridor connecting India to Europe via the Middle East has renewed focus on the three-year-old project, but analysts warn it must expand to withstand ongoing geopolitical conflicts. The India-Middle East-Europe Economic Corridor (IMEC) was first unveiled at the G20 summit in 2023 as an alternative to existing routes and China’s Belt and Road Initiative. Backed by India, the United States, Saudi Arabia, the United Arab Emirates, Israel...
The Philippines is preparing to give its coastguard more responsibilities in the contested South China Sea even as the agency faces a more basic problem: whether it has enough ships, aircraft and personnel to carry them out. The proposed overhaul comes as the coastguard is being stretched by increasingly demanding operations around Philippine-claimed waters, while funding constraints threaten to limit its ability to keep its existing assets at sea. That tension is evident in the 2027 budget. The...
A 30-year-old man was charged on Tuesday over an AI-generated image of a crocodile at Pandan Reservoir in Singapore that prompted authorities to search for the reptile and suspend water activities there. Ye Lin, a Myanmar national, was handed two charges – one count of communicating a false message and one count of obstructing the course of justice. Speaking through an interpreter, he told the court that he intended to plead guilty, and would not be engaging a lawyer. On August 20, Ye Lin...
For 28-year-old Indonesian professional Evelyn Clarissa Siregar, asking strangers to help fund her MBA in Singapore was a gamble: she knew the request was unconventional but hoped putting her dream out in public might open a door. Instead, her appeal for more than S$100,000 (US$78,000) to fund her business programme at Singapore Management University (SMU) drew fierce online criticism, with some labelling her entitled and questioning her plans. “I never expected the backlash to become this big,”...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.